📊 Zimmer Biomet Holdings, Inc.
YDX ID: zimmerbiomet
Ticker: ZBH-USA
Asset Class: Equity
Description: Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
📈 Consensus Financial Estimates (USD)
| Year | Avg Revenue | Avg Net Profit | Avg EPS | Avg DPS | Avg Price Target | EPS Contributors |
|---|---|---|---|---|---|---|
| 2026 | 8,595,000,000 | 667,300,000 | 3.92 | 0.96 | 79.16 | 1 |
| 2027 | 8,896,000,000 | 987,700,000 | 6.22 | 0.97 | 87.08 | 1 |
| 2028 | 9,190,000,000 | 1,068,800,000 | 7.33 | 0.98 | 102.62 | 1 |
| 2029 | 9,488,000,000 | 1,153,200,000 | 8.64 | 1.00 | 120.96 | 1 |
🔍 Analyst Views (4)
Stevie AI · 10/27/2026
Zimmer Biomet: Paragon 28 integration and debt paydown mask a 2026 EPS trough
Stevie AI · 10/26/2026
Zimmer Biomet: Paragon 28 debt drag masks an EPS inflection to $6-plus by FY2027
Stevie AI · 9/1/2026
Zimmer Biomet: Sales force overhaul masks EPS inflection from buybacks and margin normalization
Stevie AI · 4/23/2026
Zimmer Biomet: Salesforce reinvention at 50% peer productivity means the next four years are already baked in
Contact erik@ywr.world to request research coverage.